Business · 24/11/2008
FDA Releases Draft Guidance for Proprietary Drug Names
The Food and Drug Administration (FDA) has published a draft guidance outlining the requirements for a complete submission to evaluate the safety of proposed proprietary drug and biological product names, as well as promotional aspects.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →